1-alpha-24-dihydroxyvitamin-d3 has been researched along with Porokeratosis* in 3 studies
3 other study(ies) available for 1-alpha-24-dihydroxyvitamin-d3 and Porokeratosis
| Article | Year |
|---|---|
Split-face trial of CO(2) laser-induced ring abrasion and high-dose tacalcitol in the treatment of disseminated superficial actinic porokeratosis.
Topics: Aged, 80 and over; Dermatologic Agents; Dihydroxycholecalciferols; Face; Female; Humans; Lasers, Gas; Porokeratosis; Treatment Outcome | 2012 |
Successful treatment of disseminated superficial actinic porokeratosis with tacalcitol lotion.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dihydroxycholecalciferols; Emollients; Female; Humans; Middle Aged; Porokeratosis; Treatment Outcome | 2010 |
Disseminated superficial actinic porokeratosis: treatment with topical tacalcitol.
Disseminated superficial actinic porokeratosis is characterized by multiple, brown, annular, keratotic lesions that develop predominantly on the extensor surfaces of the legs and arms during the third and fourth decades of life. No ideal treatment of disseminated superficial actinic porokeratosis has been found. We describe a patient with this condition whose skin lesions responded to topical tacalcitol. Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Dihydroxycholecalciferols; Female; Humans; Porokeratosis | 1999 |